Let's face it - being diagnosed with and treated for breast cancer is no picnic. It can be depressing. And survivors who suffer from depression often have more complicated recoveries.  Researchers now know who is most vulnerable.

Rarely seen in the United States, nasopharyngeal carcinoma appears mostly in Southern China and Southeast Asia. Medical researchers have found a new and better method of treating this disease that substantially improves survival.

People with rheumatoid arthritis suffer from inflammation of the joints. That inflammation can spread to other organs, causing additional health problems. Atherosclerosis (hardened arteries) may be one of these problems.

Statins are widely prescribed to lower cholesterol and reduce the risk of heart attacks and strokes. Though effective, some doctors have become concerned about a rare gene that increases the risk of muscle aches, kidney damage and death in those who also take statins.

Kidney disease patients face a high risk of heart-related events like stroke. As such, patients need ways to protect against potentially deadly problems. Now, health advisors are backing a drug that does just that.

As a patient gets older, the number of treatments available becomes limited. Luckily for older patients with blood cancers, age is not a factor in getting a stem cell transplant.

Red wine has been shown to have certain health benefits, including protection against heart disease. Now, it appears that a compound found in red wine may protect against type 2 diabetes.

Quitting smoking is a healthy lifestyle choice, and many people turn to pharmaceuticals for help. But for one drug, scientists have found that the risks may outweigh the benefits.

A new drug for multiple sclerosis (MS) has shown promising results in clinical trials. The drug, called ocrelizumab, has a novel new target to treat the disease.

For women who are pregnant, reduced thyroid function can have adverse effects on both the woman's health, and that of her unborn baby. These effects can include the risk of miscarriage and premature birth, but the universal screening of pregnant women for thyroid disfunction is still controversial due to costs.